Entisar J. Almodyan, Pharm.D., BCPS, BCIDP, CMTMP, AAHIVP, is an infectious diseases clinical pharmacist, pharmacy training coordinator, and antimicrobial stewardship program coordinator at Maternity and Children Hospital, Hail Health Cluster, Saudi Arabia. Almodyan chose clinical pharmacy because it combines scientific knowledge, critical thinking, and direct patient care in a way that allows pharmacists to make a meaningful impact on patient outcomes. Early in her training, she was drawn to the complexity of medication management and the opportunity to work collaboratively with multidisciplinary health care teams to solve clinical challenges. Her interest in infectious diseases developed through caring for critically ill patients and witnessing both the lifesaving potential of antimicrobial therapy and the consequences of inappropriate antimicrobial use. She was particularly inspired by the dynamic nature of the field, where emerging pathogens, evolving resistance patterns, and rapidly changing evidence require continuous learning and adaptation. She believes that infectious diseases is one of the few specialties where pharmacists can directly influence patient outcomes while also addressing broader public health concerns such as antimicrobial resistance.
In her current position, Almodyan provides specialized infectious diseases consultation across neonatal, pediatric, critical care, and maternal health populations. She leads antimicrobial stewardship initiatives focused on optimizing antimicrobial use, combating antimicrobial resistance, and improving patient outcomes through evidence-based practice. Her work spans direct patient care, multidisciplinary collaboration, pharmacist and resident development, quality improvement, and clinical research. Working with these different populations has reinforced her belief that pharmacists play a vital role not only in individual patient care but also in advancing health care quality, education, and public health. Her professional interests include infectious diseases pharmacotherapy, antimicrobial resistance, health equity, clinical research, HIV care, and leadership development. What continues to motivate her is the opportunity to improve outcomes for patients while contributing to the global effort to preserve the effectiveness of antimicrobial therapy for future generations. Through antimicrobial stewardship, education, and research, she strives to help ensure that these lifesaving therapies remain effective for those who need them most.
Almodyan is actively engaged in national and international professional organizations, including the American College of Clinical Pharmacy (ACCP), the Infectious Diseases Society of America (IDSA), and the Society of Infectious Diseases Pharmacists. She serves as a reviewer for ACCP educational programs. She advocates for health equity by working to ensure that all patients have access to safe, effective, and evidence-based care regardless of age, background, or clinical complexity. She believes that advocacy does not always require a formal leadership position. It can begin with educating patients, supporting evidence-based decision-making, participating in quality improvement initiatives, mentoring future health care professionals, or becoming involved in professional organizations. Every effort, regardless of size, contributes to advancing the profession and improving patient care. Almodyan was recognized as an IDSA Health Equity Champion for her contributions to advancing equitable health care.
The greatest influences on Almodyan’s career have been her family, whose constant encouragement and support have inspired her to pursue her goals, embrace challenges, and strive for excellence. She has also had the privilege of learning from health care professionals who demonstrated excellence in patient care, leadership, and lifelong learning, inspiring her to continuously develop her clinical skills and contribute beyond direct patient care. She is similarly grateful to her friends and colleagues, who have come to regard her as a trusted resource for infectious diseases–related questions and complex clinical cases. Their ongoing discussions provide valuable opportunities to exchange perspectives, foster collaborative learning, and continuously refine clinical decision-making. Equally influential have been the patients and families she has encountered throughout her career, whose resilience, trust, and unique health care journeys have reinforced the importance of compassionate, evidence-based care. Together, these influences have shaped her commitment to infectious diseases pharmacy, antimicrobial stewardship, education, and research.
Almodyan encourages ACCP members, students, and residents to be intentional about building both expertise and impact. Clinical knowledge is essential, but what truly distinguishes a pharmacist is the ability to apply that knowledge to improve patient care, advance practice, and support others in their professional growth. Seek opportunities that challenge you, she advises, even when they feel outside your comfort zone. Some of the most meaningful experiences in my career, including leadership roles, research collaborations, professional service, and educational initiatives, began with opportunities that initially seemed intimidating. Growth often occurs when we are willing to embrace uncertainty and continue learning. Finally, remember that every interaction is an opportunity to make a difference. Whether caring for a patient, mentoring a learner, conducting research, or participating in antimicrobial stewardship efforts, our work has the potential to create a lasting impact. Stay curious, remain humble, and never underestimate the value of your contributions to patients, the profession, and the health care community.